6,678 trials
Stoma Colostomy
Primary: Degree of Leakage. Each Baseplate Can Have a Score From 0-24 Points Were 0 is the Best Possible Outcome (No Leakage) and 24 Points is the Worst Possible Outcome (Full…
Healthy
Primary: Peak Plasma Concentration of d-Methylphenidate — 0.00; 15.06; 25.34; 20.34 mg/L
Hypertension
Primary: Change From Baseline (Visit 3) to End of Study (Week 8) in Mean 24 Hour Ambulatory Systolic Blood Pressure (maSBP) — -7.03; -7.79 mmHg
Anesthetic Effectiveness
Primary: Successful Pulpal Anesthesia. — 37; 27; 22; 33 participants
Aortic Aneurysm
Primary: All-cause Mortality — 146; 146 participants — p=0.81
Anesthesia
Primary: Heart Rate and Blood Pressure Double Product — 9114; 8804 (beats/minute)*mmHg
Melasma
Primary: Number of Participants Showing Improvement of Melasma Based on Mexameter Readings — 18 participants
Coronary Artery Stenosis
Primary: Impact on the Trajectory of Serum and Urinary Neutrophil Gelatinase-associated Lipocalin (NGAL) Following Administration — -27.76; -11.11; -11.84; -8.23 ng/mL
HIV Infections
Primary: Number of Participants in Each Group (Study Drug vs. Placebo) With Undetectable Plasma HIV-1 RNA, as Measured by an Ultra-sensitive Assay With a Limit of Detection of 1…
Poliomyelitis
Primary: Number of Subjects Reporting Any and Grade 3 Solicited Local Symptoms — 114; 7; 258; 12 Subjects
Type 2 Diabetes · Insulin Resistance
Primary: Improvement in Glycemic Control as Assessed by Change in Hemoglobin A1c (HbA1c) — -1.23 HbA1c percentage
Severe Asthma · Moderate or Severe Major Depressive Disorder
Primary: HAM-D (Hamilton Rating Scale for Depression) — 24.8; 28.3 units on a scale
Pulmonary Disease, Chronic Obstructive
Primary: Variability in Daily FEV1, Estimated by Coefficient of Variation — 0.081; 0.079; 0.059; NA Liters
Overactive Bladder
Primary: Change From Baseline in Mean Number of Urgency Urinary Incontinence (UUI) Episodes Per 24 Hours at Week 12. — -2.85; -2.22; -3.12 Episodes per 24 hours — p=<0.0001
Ureteral Stent Occlusion · Exposure Laser · Ureterostomy; Functional Disturbance
Primary: Time to Opening of Eyes — 391.2; 446.5 seconds